Continental Chemicals Limited has delivered a strong financial performance for the third quarter of FY26, with the Board of Directors approving unaudited results that demonstrate significant growth across key financial metrics. The company's results for the quarter ended December 31, 2025, were reviewed by the Audit Committee and approved by the Board in their meeting held on January 12, 2026.

Quarterly Financial Performance

The company's Q3FY26 performance showed marked improvement compared to the previous year. Continental Chemicals reported substantial growth in profitability while maintaining steady operational revenue.

Nine-Month Performance Analysis

The nine-month period ended December 31, 2025, showcased even stronger growth momentum for Continental Chemicals. The company demonstrated consistent improvement in operational efficiency and profitability metrics.

Expense Management and Operational Efficiency

Continental Chemicals maintained disciplined cost management during Q3FY26. Total expenses for the quarter stood at ₹27.61 lakh compared to ₹29.98 lakh in Q3FY25, representing a decrease of 7.90%. Key expense components included:

• Employee Benefits Expense: ₹14.45 lakh (vs ₹14.19 lakh in Q3FY25)
• Other Expenditure: ₹10.34 lakh (vs ₹13.06 lakh in Q3FY25)
• Finance Cost: ₹1.07 lakh (vs ₹0.95 lakh in Q3FY25)
• Depreciation: ₹1.75 lakh (vs ₹1.78 lakh in Q3FY25)

Tax Position and Comprehensive Income

The company's tax expense for Q3FY26 was ₹1.17 lakh, significantly lower than ₹4.08 lakh in the corresponding quarter last year. This included current tax of ₹1.44 lakh and a deferred tax benefit of ₹0.27 lakh. Total comprehensive income for the quarter reached ₹13.54 lakh compared to ₹9.83 lakh in Q3FY25.

Corporate Structure

Continental Chemicals Limited maintains a paid-up equity share capital of ₹224.90 lakh with a face value of ₹10 per share. The company operates in a single business segment and follows Indian Accounting Standards (Ind AS) for financial reporting. The results have been prepared in accordance with Regulation 33 of SEBI (LODR) Regulations, 2015, and reviewed by statutory auditors SSVS & CO., Chartered Accountants.

Continental Chemicals Limited has scheduled a board meeting for January 12, 2026, to consider its unaudited quarterly financial results for Q3FY26 and formally acknowledge the resignation of Chief Financial Officer Navneet Kumar. The company filed the board meeting intimation with the Bombay Stock Exchange under Regulation 29 of SEBI (LODR) Regulations, 2015 on January 3, 2026.

Board Meeting Details

The board meeting will be held at 4:00 PM at the company's registered office located at A-7, Sector-7, Noida-201301. The primary agenda includes consideration and recording of unaudited quarterly financial results for the quarter ended December 31, 2025.

CFO Resignation Acknowledgment

The board will also formally acknowledge Mr. Navneet Kumar's resignation from his position as Chief Financial Officer. Kumar, who serves as both CFO and Key Managerial Personnel (KMP), submitted his resignation on December 13, 2025, which becomes effective from January 14, 2026.

Regulatory Compliance

The board meeting intimation was filed pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015. Company Secretary Sakshi Dhawan, with membership number ACS33279, signed the regulatory filing on behalf of Continental Chemicals Limited. The company has confirmed that Kumar's resignation is attributed to personal reasons, specifically his decision to pursue another career opportunity, with no other material reasons beyond those disclosed.

Transition Planning

The board meeting agenda includes consideration of any other matters with the board's permission, which may encompass succession planning for the CFO position. Kumar has committed to ensuring a smooth handover of his responsibilities as directed by management. The company has indicated that the Board of Directors will appoint Kumar's successor in due course.